Prognostic factors and impact of adjuvant chemotherapy for uterine leiomyosarcoma

Gynecologic Oncology

Volumn 100, Issue 1, 2006, Pages 166-172

  Wu, Tzu I ^a   Chang, Ting Chang ^a   Hsueh, Swei ^a   Hsu, Kuang Hung ^b   Chou, Hung Hsueh ^a   Huang, Huei Jean ^a   Lai, Chyong Huey ^a  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^b CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

Adjuvant therapy; Chemotherapy; Prognostic factors; Uterine leiomyosarcoma

Indexed keywords

CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; EPIRUBICIN; IFOSFAMIDE; VINCRISTINE;

ADJUVANT CHEMOTHERAPY; ADULT; AGED; ARTICLE; CANCER REGISTRY; CANCER SURGERY; CANCER SURVIVAL; CANCER SURVIVOR; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC PROCEDURE; FEMALE; FOLLOW UP; HUMAN; LEIOMYOSARCOMA; MULTIMODALITY CANCER THERAPY; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; REGRESSION ANALYSIS; RETROSPECTIVE STUDY; UTERUS CARCINOMA; UTERUS LEIOMYOSARCOMA;

ADULT; AGED; AGED, 80 AND OVER; CHEMOTHERAPY, ADJUVANT; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LEIOMYOSARCOMA; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; SURVIVAL RATE; UTERINE NEOPLASMS;

EID: 29144433592     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2005.08.010     Document Type: Article

References (29)

1. C. Zaloudek, and M.R. Hendrickson Mesenchymal tumors of the uterus R.J. Kurman Blaustein's pathology of the female genital tract 2002 Springer-Verlag, Inc. New York 578 583
2. F.J. Major, J.A. Blessing, and S.G. Silverberg Prognostic factors in early-stage uterine sarcoma Cancer 71 1993 1902 1909
3. L. Livi, F. Paiar, and N. Shah Uterine sarcoma: twenty-seven years of experience Int. J. Radiat. Oncol., Biol., Phys. 57 2003 1366 1373
4. R. Blom, C. Guerrieri, O. Stal, H. Malmstrom, and E. Simonsen Leiomyosarcoma of the uterus: a clinicopathologic, DNA flow cytometric, p53, and mdm-2 analysis of 49 cases Gynecol. Oncol. 68 1998 54 61
5. R.N. Nordal, K.E. Kjǿrstad, A.E. Stenwig, and C.G. Trope Leiomyosarcoma (LMS) and endometrial stromal sarcoma (ESS) of the uterus. A survey of patients treated in the Norwegian Radium Hospital 1976-1985 Int. J. Gynecol. Cancer 3 1993 110 115
6. G. Echt, J. Jepson, and J. Steel Treatment of uterine sarcomas Cancer 66 1990 35 39
7. T.A. Dinh, E.A. Oliva, A.F. Fuller, H. Lee, and A. Goodman The treatment of uterine leiomyosarcoma. Results form a 10-year experience (1990-1999) at the Massachusetts General Hospital Gynecol. Oncol. 92 2004 648 652
8. S.E. Brooks, M. Zhan, T. Cote, and C.R. Baquet Surveillance, epidemiology, and end results analysis of 2677 cases of uterine sarcoma 1989-1999 Gynecol. Oncol. 93 2004 204 208
9. L.A. Aaro, R.E. Symmonds, and M.B. Dockerty Sarcoma of the uterus: a clinical and pathologic study of 177 cases Am. J. Obstet. Gynecol. 94 1966 101 109
10. W. Hoffmann, S. Schmandt, R.D. Kortmann, M. Schiebe, J. Dietl, and M. Bamberg Radiotherapy in the treatment of uterine sarcomas: a retrospective analysis of 54 cases Gynecol. Obstet. Invest. 42 1996 49 57
11. K. Mayerhofer, A. Obermair, and G. Windbichler Leiomyosarcoma of the uterus: a clinicopathologic multicenter study of 71 cases Gynecol. Oncol. 74 1999 196 201
12. E.V. Hannigan, and J.D. Gomez Leiomyosarcoma of the uterus Am. J. Obstet. Gynecol. 134 1979 557 564
13. W.A. Peters III, D.R. Howard, and W.A. Anderson Uterine smooth-muscle tumors of uncertain malignant potential Obstet. Gynecol. 83 1994 1015 1020
14. R.L. Giuntoli, D.S. Metzinger, and C.S. DiMarco Retrospective review of 208 patients with leiomyosarcoma of the uterus: prognostic indicators, surgical management, and adjuvant therapy Gynecol. Oncol. 89 2003 460 469
15. G.A. Omura, J.A. Blessing, and F. Majors A randomized clinical trial of adjuvant adriamycin in uterine sarcoma: a gynecologic oncology group study J. Clin. Oncol. 3 1985 1240
16. A. Gadducci, F. Landoni, and E. Sartori Uterine leiomyosarcoma: analysis of treatment failures and survival Gynecol. Oncol. 62 1996 25 32
17. J.L. Benedet, H. Bender, and H. Jones III FIGO staging classifications and clinical practice guidelines in the management of gynecologic cancers Int. J. Gynecol. Obstet. 70 2000 209 262
18. C.H. Lai, S. Hsueh, and T.C. Chang The role of DNA flow cytometry in borderline malignant ovarian tumors Cancer 78 1996 794 802
19. SPSS for windows, Rel 11.0.1. 2001. Chicago: SPSS. Inc.
20. SAS Institute. SAS Statistical Package, Version 8.1. Cary, NC: SAS Institute, Inc.; 2000.
21. A. Lissoni, G. Cormio, and C. Bonazzi Fertility-sparing surgery in uterine leiomyosarcoma Gynecol. Oncol. 70 1998 348 350
22. M.M. Leitao, Y. Sonoda, M.F. Brennan, R.R. Barakat, and D.S. Chi Incidence of lymph node and ovarian metastases in leiomyosarcoma of the uterus Gynecol. Oncol. 91 2003 209 212
23. P.J. Disaia, and W.T. Creasman Sarcoma of uterus Clinical gynecologic oncology 6th ed. 2002 St. Louis: Mosby, Inc. 175 183
24. B.A. Goff, L.W. Rice, and D. Fleischhacker Uterine leiomyosarcoma and endometrial stromal sarcoma: lymph node metastases and sites of recurrence Gynecol. Oncol. 50 1993 105 109
25. T.H. Knocke, H. Kucera, and N. dörfler Results of postoperative radiotherapy in the treatment of sarcoma of the corpus uteri Cancer 83 1998 1972 1979
26. G. Echt, J. Jepson, and J. Steel Treatment of uterine sarcomas Cancer 66 1990 35 39
27. C. Krasner, and M.V. Seiden Treatment of uterine sarcomas A.F. Fuller M.V. Seiden R.H. Young Uterine cancer 2004 BC Decker, Inc. Ontario 213 226
28. P. Pautier, A. Rey, and C. Haie-Meder Adjuvant chemotherapy with cisplatin, ifosfamide, and doxorubicin followed by radiotherapy in localized uterine sarcomas: results of a case-control study with radiotherapy alone Int. J. Gynecol. Cancer 14 2004 1112 1117
29. R. Winter, A. Östör, K. Kapp, and E. Petru Primary treatment of uterine sarcomas D.M. Gershenson W.P. McGuire M. Gore M.A. Quinn G. Thomas Gynecologic cancer: controversies in management 2004 Elsevier Churchill livingstone Inc Pennsylvania 301 316